Next Avenue Logo
Advertisement

PBS NewsHour

A sign of the Biogen company. new Alzheimer's drug, aducanumab, Aduhelm, FDA, Next Avenue

Why the FDA Approved a Controversial Alzheimer’s Drug

The FDA says the drug aducanumab may slow Alzheimer's progression, but approval goes against the agency's independent advisers who say it wasn't effective in clinical trials
June 8, 2021
Next Avenue LogoMeeting the needs and unleashing the potential of older Americans through media
©2022 Next AvenuePrivacy PolicyTerms of Use
A nonprofit journalism website produced by:
TPT Logo